REFERENCES
- Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356(9227):411–417.
- Elliott MA, Nichols WL. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mayo Clin Proc. 2001;76(11):1154–1162.
- Khanna A, McCullough PA. Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. Rev Cardiovasc Med. 2003;4(4):255–259.
- Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994;46(2):287–296.
- Larsson SO. On coagulation and fibrinolysis in uremic patients on maintenance hemodialysis. Acta Med Scand. 1971; 189(6):453–462.
- Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J. Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron. 1987;45(3):207–210.
- Hellem A, Owren PA. The mechanism of the hemostatic function of blood platelets. Acta Hematol. 1964;31:230–238.
- Castaldi PA, Rozenberg MC, Stewart JH. The bleeding disorder of uremia. A qualitative platelet defect. Lancet. 1966;2(7454):66–69.
- Nakamura Y, Tomura S, Tachibana K, Chida Y, Marumo F. Enhanced fibrinolytic activity during the course of hemodialysis. Clin Nephrol. 1992;38(2):90–96.
- Sreedhara R, Itagaki I, Hakim RM. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Am J Kidney Dis. 1996;27(3):355–364.